» Articles » PMID: 20809113

Demographic Differences in Incidence for Pituitary Adenoma

Overview
Journal Pituitary
Specialty Endocrinology
Date 2010 Sep 3
PMID 20809113
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Incidence estimates for pituitary adenomas vary widely, suggesting the effects of numerous risk factors or varying levels of tumor surveillance. We studied the epidemiology of pituitary adenomas using 2004-2007 data collected by 17 Surveillance, Epidemiology, and End Results Programs in the United States (N = 8,276). We observed that incidence rates generally increased with age and were higher in females in early life and higher in males in later life. Males are diagnosed with larger tumors on average than females. Diagnosis may be delayed for males, giving tumors a chance to grow larger before clinical detection. We also observed that American Blacks have higher incidence rates for pituitary adenomas compared with other ethnic groups. There are several potential explanations for this finding with some evidence that at least part of the effect may be due to differential diagnosis between races.

Citing Articles

Radiological and Immunohistochemical Characteristics of PitNETs in 79 Patients Undergoing Neurosurgery.

Krzentowska A, Czepko R, Adamek D, Filipowicz M, Broniatowska E, Golkowski F Cancers (Basel). 2025; 17(4).

PMID: 40002261 PMC: 11852720. DOI: 10.3390/cancers17040666.


Endocrine Outcome and Quality of Life After Transsphenoidal Resection of Pituitary Adenoma-A Prospective Randomized Single-Blinded Study Comparing Endoscopic Versus Microscopic Resection.

Pala A, Grubel N, Mayer B, Becker R, Sommer F, Schmitz B Neurol Int. 2025; 17(1).

PMID: 39852769 PMC: 11767373. DOI: 10.3390/neurolint17010005.


Differences in tumor size, clinical, demographic, and socioeconomic profiles of central nervous system tumors among a racially diverse cohort: A retrospective case-control study.

Kim K, Lew R, Higashihara T, Yamashita S, Pang M, Stafford M Surg Neurol Int. 2025; 15():459.

PMID: 39777174 PMC: 11704430. DOI: 10.25259/SNI_190_2024.


Determinants of quality of life following resection of skull base tumors: a systematic review.

Sperl V, Rhomberg T, Kretschmer T Front Oncol. 2025; 14:1473261.

PMID: 39759154 PMC: 11696366. DOI: 10.3389/fonc.2024.1473261.


Influence of gender and sexual hormones on outcomes after pituitary surgery: a systematic review and meta-analysis.

Theiler S, Hegetschweiler S, Staartjes V, Spinello A, Brandi G, Regli L Acta Neurochir (Wien). 2023; 165(9):2445-2460.

PMID: 37555999 PMC: 10477253. DOI: 10.1007/s00701-023-05726-z.


References
1.
Melmed S . Mechanisms for pituitary tumorigenesis: the plastic pituitary. J Clin Invest. 2003; 112(11):1603-18. PMC: 281651. DOI: 10.1172/JCI20401. View

2.
Bach P, Cramer L, Warren J, Begg C . Racial differences in the treatment of early-stage lung cancer. N Engl J Med. 1999; 341(16):1198-205. DOI: 10.1056/NEJM199910143411606. View

3.
Morris A, Billingsley K, Hayanga A, Matthews B, Baldwin L, Birkmeyer J . Residual treatment disparities after oncology referral for rectal cancer. J Natl Cancer Inst. 2008; 100(10):738-44. PMC: 2766763. DOI: 10.1093/jnci/djn145. View

4.
Fan K, Kovi J, EARLE K . The ethnic distribution of primary central nervous system tumors: AFIP, 1958 to 1970. J Neuropathol Exp Neurol. 1977; 36(1):41-9. DOI: 10.1097/00005072-197701000-00005. View

5.
Ciccarelli A, Daly A, Beckers A . The epidemiology of prolactinomas. Pituitary. 2006; 8(1):3-6. DOI: 10.1007/s11102-005-5079-0. View